Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

574 ARTÍCULOS , VIENDO DEL 346 AL 360

A review on α-mangostin as a potential multi-target-directed ligand for Alzheimer's disease

Yang A, Liu C, Wu J, Kou X, Shen R.

Eur J Pharmacol. 2021 Apr 15;897:173950. doi: 10.1016/j.ejphar.2021.173950. Epub 2021 Feb 16.

Role of natural products for the treatment of Alzheimer's disease

Noori T, Dehpour AR, Sureda A, Sobarzo-Sanchez E, Shirooie S.

Eur J Pharmacol. 2021 May 5;898:173974. doi: 10.1016/j.ejphar.2021.173974. Epub 2021 Feb 27.

Alzheimer's disease

Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J, van der Flier WM.

Lancet. 2021 Apr 24;397(10284):1577-1590. doi: 10.1016/S0140-6736(20)32205-4. Epub 2021 Mar 2.

[« Forum Passerelle »: an opportunity for caregivers to meet the professionals of service and support in Alzheimer's disease and related diseases.]

Novais T, Vanhems E, Baritel M, Nier AC, Kyprianou A, Buisson B, Rouissi S, Richard G, Krolak-Salmon P, Coste MH, Loin L.

Geriatr Psychol Neuropsychiatr Vieil. 2021 Mar 1;19(1):102-109. doi: 10.1684/pnv.2021.0912.

Donanemab in Early Alzheimer's Disease

Mintun MA, Lo AC, Duggan Evans C, Wessels AM, Ardayfio PA, Andersen SW, Shcherbinin S, Sparks J, Sims JR, Brys M, Apostolova LG, Salloway SP, Skovronsky DM.

N Engl J Med. 2021 May 6;384(18):1691-1704. doi: 10.1056/NEJMoa2100708. Epub 2021 Mar 13.

Virtual care for patients with Alzheimer disease and related dementias during the COVID-19 era and beyond

Gosse PJ, Kassardjian CD, Masellis M, Mitchell SB.

CMAJ. 2021 Mar 15;193(11):E371-E377. doi: 10.1503/cmaj.201938.

Physical Exercise and Alzheimer's Disease: Effects on Pathophysiological Molecular Pathways of the Disease

López-Ortiz S, Pinto-Fraga J, Valenzuela PL, Martín-Hernández J, Seisdedos MM, García-López O, Toschi N, Di Giuliano F, Garaci F, Mercuri NB, Nisticò R, Emanuele E, Lista S, Lucia A, Santos-Lozano A.

Int J Mol Sci. 2021 Mar 12;22(6):2897. doi: 10.3390/ijms22062897.

A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody

Swanson CJ, Zhang Y, Dhadda S, Wang J, Kaplow J, Lai RYK, Lannfelt L, Bradley H, Rabe M, Koyama A, Reyderman L, Berry DA, Berry S, Gordon R, Kramer LD, Cummings JL.

Alzheimers Res Ther. 2021 Apr 17;13(1):80. doi: 10.1186/s13195-021-00813-8.

Prospects of Saffron and its Derivatives in Alzheimer's Disease

Zandi N, Pazoki B, Momeni Roudsari N, Lashgari NA, Jamshidi V, Momtaz S, Abdolghaffari AH, Akhondzadeh S.

Arch Iran Med. 2021 Mar 1;24(3):233-252. doi: 10.34172/aim.2021.35.

The Effects of Long-term Medication Use in Alzheimer Disease

Karceski S.

Neurology. 2021 Apr 27;96(17):e2247-e2250. doi: 10.1212/WNL.0000000000011843.

Interventional Study to Evaluate the Clinical Effects and Safety of the Nutraceutical Compound BrainUp-10® in a Cohort of Patients with Alzheimer's Disease: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Trial

Guzman-Martinez L, Farías GA, Tapia JP, Sánchez MP, Fuentes P, Gloger S, Maccioni RB.

J Alzheimers Dis. 2021;81(3):1231-1241. doi: 10.3233/JAD-201501.

Leveraging hallmark Alzheimer's molecular targets using phytoconstituents: Current perspective and emerging trends

Dhage PA, Sharbidre AA, Dakua SP, Balakrishnan S.

Biomed Pharmacother. 2021 Jul;139:111634. doi: 10.1016/j.biopha.2021.111634. Epub 2021 May 6.

Safety and Tolerability of GRF6019 Infusions in Severe Alzheimer's Disease: A Phase II Double-Blind Placebo-Controlled Trial

Hannestad J, Duclos T, Chao W, Koborsi K, Klutzaritz V, Beck B, Patel AK, Scott J, Thein SG, Cummings JL, Kay G, Braithwaite S, Nikolich K.

J Alzheimers Dis. 2021;81(4):1649-1662. doi: 10.3233/JAD-210011.

Does the application of acetylcholinesterase inhibitors in the treatment of Alzheimer's disease lead to depression?

Mitić M, Lazarević-Pašti T.

Expert Opin Drug Metab Toxicol. 2021 Jul;17(7):841-856. doi: 10.1080/17425255.2021.1931681. Epub 2021 Jun 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias